World Anti-Doping Code • 20151   PARTDoping Control50ARTICLE 7  Results Management7.3  Notific ation After Review Regarding  Adverse Analytical Findings  if the review of an adverse analytical finding under Article 7.2 does not reveal an applicable tue or entitlement to a tue as provided in the international Standard for Therapeutic Use Exemptions, or departure that caused the adverse analytical finding, the anti-doping organization shall promptly notify the athlete, in the manner set out in Articles 14.1.1 and 14.1.3 and its own rules, of: (a) the adverse analytical finding; (b) the anti-doping rule violated; and (c) the athlete’s right to promptly request the analysis of the B Sample or, failing such request, that the B Sample analysis may be deemed waived; (d) the scheduled date, time and place for the B Sample analysis if the athlete or anti-doping organization chooses to request an analysis of the B Sample; (e) the opportunity for the athlete and/or the athlete’s representative to attend the B Sample opening and analysis within the time period specified in the international Standard for Laboratories if such analysis is requested; and (f) the athlete’s right to request copies of the A and B Sample laboratory documentation package which includes information as required by the international Standard for Laboratories.